Home › Pancreatic Cancer › Maryland
Pancreatic Cancer clinical trials in Maryland
44 studies for Pancreatic Cancer are looking for participants at sites in Maryland.
Cities in Maryland
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
- National Institutes of Health Clinical Center, Bethesda
RecruitingObservational study
Ages 2 to 100 · All sexes · Updated Oct 2, 2026 · NCT01950572Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
- National Institutes of Health Clinical Center, Bethesda
RecruitingPhase 1
Ages 18 to 120 · All sexes · Updated Oct 2, 2026 · NCT06885697Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- Maryland Oncology, Columbia
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT07562152Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
- National Institutes of Health Clinical Center, Bethesda
RecruitingPhase 2
Ages 18 to 72 · All sexes · Updated Oct 2, 2026 · NCT01174121Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer
- National Institutes of Health Clinical Center, Bethesda
RecruitingObservational study
Ages 2 and older · All sexes · Updated Oct 1, 2026 · NCT01915225A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Johns Hopkins University, Baltimore
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06172478Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
- Johns Hopkins University, Baltimore
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07621718A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- JHU Oncology Central Kit Services, Baltimore
- Johns Hopkins Hospital, Baltimore
- Oncology Investigational Drug Service (IDS), Baltimore
- and 1 more
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06989437Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
- National Institutes of Health Clinical Center, Bethesda
RecruitingPhase 1
Ages 12 to 120 · All sexes · Updated Sep 23, 2026 · NCT04222413Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
- Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins & Sibley Memorial Hospital, Baltimore
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT07252232A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
- University of Maryland School - Division of Hematology/Oncology, Baltimore
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07409272Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- The Sidney Kimmel Comprehensive Cancer Center at John Hopkins, Baltimore
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06445062Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts
- The Johns Hopkins University School of Medicine, Baltimore
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT06271291Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
- Johns Hopkins, Baltimore
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07349537A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
- Johns Hopkins Hospital, Baltimore
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07492680Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
RecruitingObservational study
Up to age 17 · All sexes · Updated Sep 11, 2026 · NCT06651580Total Pancreatectomy With Islet Autotransplantation (TPIAT) for High-Risk Patients With Pancreatic Tumors
- Johns Hopkins Hospital, Baltimore
Recruiting
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT07360119Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
- Christiana Care - Union Hospital, Elkton
RecruitingObservational study
Ages 50 to 75 · All sexes · Updated Sep 4, 2026 · NCT04239573A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
- Johns Hopkins University, Baltimore
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT07644559The Vanguard Study: Testing a New Way to Screen for Cancer
- Walter Reed National Military Medical Center, Bethesda
RecruitingHealthy volunteers welcome
Ages 45 to 75 · All sexes · Updated Sep 2, 2026 · NCT06995898Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
- Sinai Hospital of Baltimore, Baltimore
- William E Kahlert Regional Cancer Center/Sinai Hospital, Westminster
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT06958328Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
- National Institutes of Health Clinical Center, Bethesda
RecruitingPhase 1/2
Ages 18 to 72 · All sexes · Updated Aug 24, 2026 · NCT03190941Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
- National Institutes of Health Clinical Center, Bethesda
RecruitingPhase 1/2
Ages 18 to 72 · All sexes · Updated Aug 13, 2026 · NCT02830724Pancreatic Cancer Registry: For Any Person With a Personal or Family History
- Johns Hopkins Hospital, Baltimore
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Aug 5, 2026 · NCT02886247KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer
- Sidney Kimmel Comprehensive Cancer Center, Baltimore
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT06411691EXoPERT EMERALD Clinical Study
- John Hopkins University, Baltimore
RecruitingObservational studyHealthy volunteers welcome
Ages 45 and older · All sexes · Updated Jul 1, 2026 · NCT07186296Mutant KRAS -Targeted Long Peptide Vaccine for Patients at High Risk of Developing Pancreatic Cancer
- Sidney Kimmel Comprehensive Cancer Center, Baltimore
RecruitingPhase 1Healthy volunteers welcome
Ages 40 and older · All sexes · Updated Jun 30, 2026 · NCT05013216Integrated Cancer Repository for Cancer Research
- Northwest Hospital, Randallstown
- William E. Kahlert Regional Cancer Center, Westminster
RecruitingObservational studyHealthy volunteers welcome
Ages 19 to 110 · All sexes · Updated Jun 29, 2026 · NCT02012699Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
- Johns Hopkins University, Baltimore
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jun 3, 2026 · NCT06040541A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
- Johns Hopkins Hospital, Baltimore
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated May 28, 2026 · NCT07223047Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
- Sinai Hospital of Baltimore, Baltimore
- Christiana Care - Union Hospital, Elkton
- Northwest Hospital Center, Randallstown
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 22, 2026 · NCT06998940Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- Johns Hopkins University, Baltimore
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated May 15, 2026 · NCT05379985NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic Cancer
- Sidney Kimmel Comprehensive Cancer Center, Baltimore
RecruitingPhase 2
Ages 18 and older · All sexes · Updated May 5, 2026 · NCT06941857A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
- Johns Hopkins University, Baltimore
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Apr 22, 2026 · NCT07020221Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors
- National Institutes of Health Clinical Center, Bethesda
RecruitingPhase 2
Ages 12 and older · All sexes · Updated Apr 20, 2026 · NCT04074135Diagnostic Strategies, Risk Assessment and Progression of Pancreatic Cysts
- The Johns Hopkins Hospital, Baltimore
RecruitingObservational study
Ages 18 and older · All sexes · Updated Mar 2, 2026 · NCT04473794A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
- Ohio State University-Telemedicine, Baltimore
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Feb 17, 2026 · NCT06906562LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
- Christiana Care - Union Hospital, Elkton
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jan 9, 2026 · NCT06073431Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Dec 3, 2025 · NCT06782932SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Baltimore
- Massive Bio SYNERGY-AI site, Bethesda
- Massive Bio SYNERGY-AI site, Silver Spring
- and 1 more
RecruitingObservational study
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.